Summary
Recent data suggests that reduced nerve blood flow is implicated in the aetiology of experimental diabetic neuropathy, which may be prevented by manipulations that reduce receptor-mediated vasoconstrictor activity. This investigation examines the effects of nifedipine, a voltage-sensitive calcium channel antagonist which has a direct vasodilatory effect on vessels, on nerve conduction, hypoxic resistance and capillary density in streptozotocin-induced diabetic rats. Treated and non-treated non-diabetic and diabetic groups were employed. Diabetes duration was 2 months. Treatment was preventive, groups received a nifedipine dietary supplement (40 mg · kg−1 · day−1) for 2 months from the start of the study. Conduction was measured in sciatic motor branches supplying tibialis anterior and gastrocnemius muscles, and sensory saphenous nerve. Diabetes resulted in a 23–28 % reduction in motor conduction velocity (p<0.001), and a 15% deficit for sensory saphenous nerve (p<0.001). In the nifedipine-treated diabetic group, motor and sensory conduction deficits were minimal compared with non-treated diabetes (p<0.001). Nifedipine treatment had no significant effect on conduction velocity in nondiabetic rats. In vitro measurement of sciatic nerve hypoxic resistance revealed a 60 % increase in the time taken for compound action potential amplitude to reach half its initial value with diabetes (p<0.001). This was not significantly affected by nifedipine treatment. Experimental diabetes or nifedipine treatment did not significantly alter sciatic nerve endoneurial capillary density. We conclude that nifedipine, a vasodilator which acts directly on vascular smooth muscle, prevents nerve conduction deficits in experimental diabetes.
Article PDF
Similar content being viewed by others
References
Low PA, Tuck RR, Takeuchi M (1987) Nerve microenvironment in diabetic neuropathy. In: Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte D (eds) Diabetic neuropathy. Saunders, Philadelphia, pp 266–278
Tuck RR, Schmelzer JD, Low PA (1984) Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 107: 935–950
Greene DA, Lattimer SA (1984) Action of sorbinil in diabetic peripheral nerve. Relationship of polyol (sorbitol) pathway inhibition to a myo-inositol mediated defect in sodium-potassium ATPase activity. Diabetes 33: 712–716
Cameron NE, Cotter MA, Ferguson K, Robertson S, Radcliffe MA (1991) Effects of chronic α-adrenergic receptor blockade on peripheral nerve conduction, hypoxic resistance, polyols, Na-K ATPase activity and vascular supply in streptozotocin-diabetic rats. Diabetes 40: 1652–1658
Cameron NE, Cotter MA, Low PA (1991) Nerve blood flow in early and experimental diabetes in rats: relation to conduction deficits. Am J Physiol 261: E1-E8
Morff RJ (1990) Microvascular reactivity to norephinephrine at different arteriolar levels and durations of streptozotocin-induced diabetes. Diabetes 39: 354–360
Ward KK, Low PA, Schmeltzer JD, Zochodone DW (1989) Prostacyclin and noradrenaline in peripheral nerve of chronic experimental diabetes. Brain 112: 107–208
Cameron NE, Cotter MA, Robertson S (1992) Angiotensin converting enzyme inhibition prevents development of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocindiabetic rats. Diabetologia 35: 12–18
Dunn WR, McGrath JC, Wilson VG (1991) Postjunctional α-adrenoceptors in the rabbit isolated distal saphenous artery: indirect sensitivity to prazosin of responses to noradrenaline mediated via postjunctional α2-adrenoreceptors. Br J Pharmacol 103: 1484–1492
Rang HP, Dale MM (1991) Pharmacology. Churchill Livingstone, Edinburgh
Nayler WG, Dillon JS, Sturrock WJ (1988) Calcium antagonists and hypertension. Clin Exp Pharmacol Physiol 15: 93–103
Pieper GM, Gross GJ (1990) Augmented vascular relaxation to KT-362 in diabetic rat aorta: comparison to diltiazem. J Cardiovasc Pharmacol 16: 394–400
Cameron NE, Cotter MA, Robertson S (1989) The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats. Q J Exp Physiol 74: 917–926
Cameron NE, Cotter MA, Robertson S (1991) Effects of essential fatty acid supplementation on peripheral nerve and skeletal muscle function and capillarization in streptozotocin diabetic rats. Diabetes 40: 532–539
Ziada AMAR, Hudlicka O, Tyler KR, Wright AJA (1984) The effect of long term vasodilation on capillary growth and performance in rabbit heart and skeletal muscle. Cardiovasc Res 18: 724–732
Greene DA, Lattimer SA, Ulbrecht J, Carroll P (1985) Glucose-induced alterations in nerve metabolism: current perspective on the pathogenesis of diabetic neuropathy and future directions for research and therapy. Diabetes Care 8: 290–299
Triggle DJ (1982) Biochemical pharmacology of calcium blockers. In: Flaim SF, Zelis R (eds) Calcium blockers: mechanism of actions and clinical applications. Williams and Wilkins, Baltimore, pp 121–134
Flaim SF (1982) Comparative pharmacology of calcium blockers based on studies of vascular smooth muscle. In: Flaim SF, Zelis R (eds) Calcium blockers: mechanism of actions and clinical applications. Williams and Wilkins, Baltimore, pp 155–178
Flaim SF, Kanda K (1982) Comparative pharmacology of calcium channel blockers based on studies of cardiac output distribution. In: Flaim SF, Zelis R (eds) Calcium blockers: mechanism of actions and clinical applications. Williams and Wilkins, Baltimore, pp 179–192
White RP, Carrier GO (1988) Enhanced vascular α-adrenergic neuroeffector system in diabetes: importance of calcium. Am J Physiol 255: H1036-H1042
White RP, Carrier GO (1990) Vascular contraction induced by activation of membrane calcium ion channels is enhanced in streptozotocin-diabetes. J Pharmacol Exp Ther 253: 1057–1062
Macleod KM, McNeill JH (1984) The influence of chronic experimental diabetes on contractile responses of rat isolated blood vessels. Can J Physiol Pharmacol 63: 52–57
Scarborough NL, Carrier GO (1983) Increased alpha-2 adrenoceptor mediated vascular contraction in diabetic rats. J Autonom Pharmacol 3: 177–183
Harris KH, Macleod KM (1988) Influence of the endothelium on contractile responses of arteries from diabetic rats. Eur J Pharmacol 153: 55–64
Yagi S, Takata S, Kiyokawa H et al. (1988) Effects of insulin on vasoconstrictive responses to norepinephrine and angiotensin II in the rabbit femoral artery and vein. Diabetes 37: 1064–1067
Durante W, Sen AK, Sunhara FA (1988) Impairment of endothelium-dependent relaxation in aortae from spontaneously diabetic rats. Br J Pharmacol 94: 463–468
Pieper GM, Gross GJ (1988) Oxygen free radicals abolish endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol 255: H825-H833
Kappagoda T, Jayakody L, Rajotte R, Thomson ABR, Senaratne PJ (1989) Endothelium-dependent relaxation to acetylcholine in the aorta of streptozotocin induced diabetic-rat. Clin Invest Med 12: 187–193
Cameron NE, Cotter MA (1992) Modulation of endothelium dependent relaxation by polyol pathway activity in aorta from chronic streptozotocin-diabetic rats. Eur J Clin Invest 22: A53 (Abstract)
Barnes AJ, Locke P, Scudder PR, Dormandy TL, Dormandy JA (1977) Is hyperviscosity a treatable component of diabetic microcirculatory disease? Lancet II: 789–791
Lattimer SA, Sima AAF, Greene DA (1989) In vitro correction of impaired Na+-K+ATPase in diabetic nerve by protein kinase C agonists. Am J Physiol 256: E264-E269
Greene DA, Lattimer SA (1983) Impaired rat sciatic nerve sodium-potassium adenosine triphosphate in acute streptozotocin diabetes and its correction by dietary myo-inositol supplementation. J Clin Invest 72: 1058–1063
Lambourne JE, Brown AM, Calcutt N, Tomlinson DR, Willars GB (1988) Adenosine triphosphatase in nerves and ganglia of rats with streptozotocin-induced diabetes or galactosaemia: effects of aldose reductase inhibition. Diabetologia 31: 379–384
Kihara M, Low PA (1990) Regulation of rat nerve blood flow: role of epineurial α-receptors. J Physiol 422: 145–152
Hudlicka O, Tyler KR (1986) Angiogenesis: the growth of the vascular system. Academic Press, New York
Berridge MY (1975) The interaction of cyclic neucleotides and calcium in the control of cellular activity. Adv Cyclic Neucleotide Res 6: 1–98
D'Amore PA, Shepro D (1977) Stimulation of growth and calcium influx in cultured bovine aortic cells by platelets and vasoactive substances. J Cell Physiol 92: 177–184
Zochodne DW, Huang Z, Ward K, Low PA (1990) Guanethidine adrenergic sympathectomy augments endoneurial perfusion and lowers endoneurial microvascular resistance. Brain Res 519: 112–117
Afzal N, Ganguly PK, Dhalla KS, Pierce GN, Singal PK, Dhalla NS (1988) Beneficial effects of verapamil in diabetic cardiomyopathy. Diabetes 37: 936–942
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Robertson, S., Cameron, N.E. & Cotter, M.A. The effect of the calcium antagonist nifedipine on peripheral nerve function in streptozotocin-diabetic rats. Diabetologia 35, 1113–1117 (1992). https://doi.org/10.1007/BF00401363
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00401363